Ujjawal Overseas (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.40 M
as on 23-10-2024
- Company Age 30 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.75 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.40 Cr
as on 23-10-2024
- Revenue -10.93%
(FY 2023)
- Profit -26.72%
(FY 2023)
- Ebitda -38.48%
(FY 2023)
- Net Worth 3.07%
(FY 2023)
- Total Assets 16.03%
(FY 2023)
About Ujjawal Overseas (India)
The Corporate was formerly known as Ujjwal Overseas (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹4.75 Cr. The company has closed loans amounting to ₹3.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hukam Goel and Krishna Goel serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PTC063081
- Company No.
063081
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Ujjawal Overseas (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hukam Goel  | Director | 01-Dec-1994 | Current |
| Krishna Goel | Director | 01-Dec-1994 | Current |
Financial Performance of Ujjawal Overseas (India).
Ujjawal Overseas (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.93% decrease. The company also saw a substantial fall in profitability, with a 26.72% decrease in profit. The company's net worth moved up by a moderate rise of 3.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ujjawal Overseas (India)?
In 2023, Ujjawal Overseas (India) had a promoter holding of 31.46% and a public holding of 68.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Deify Health Care Private LimitedActive 34 years 3 months
Hukam Goel and Krishna Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Mar 2017 | ₹4.75 Cr | Open |
Corporation Bank Creation Date: 29 Jun 2011 | ₹2.50 Cr | Satisfied |
Corporation Bank Creation Date: 22 May 2009 | ₹9.00 M | Satisfied |
How Many Employees Work at Ujjawal Overseas (India)?
Unlock and access historical data on people associated with Ujjawal Overseas (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ujjawal Overseas (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ujjawal Overseas (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
